-
1
-
-
0024080513
-
The hypnic headache syndrome
-
Raskin NH. The hypnic headache syndrome. Headache. 1988;28:534-536.
-
(1988)
Headache
, vol.28
, pp. 534-536
-
-
Raskin, N.H.1
-
2
-
-
0346031709
-
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
-
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):10-73.
-
(1988)
Cephalalgia
, vol.8
, Issue.7 SUPPL.
, pp. 10-73
-
-
-
3
-
-
22944465152
-
The International Classification of Headache Disorders II
-
Headache Classification Committee. The International Classification of Headache Disorders II. Cephalalgia. 2004;24 (supp 1):49-54.
-
(2004)
Cephalalgia
, vol.24
, Issue.1 SUPPL.
, pp. 49-54
-
-
-
4
-
-
0037465830
-
Hypnic headache: Clinical features, pathophysiology and treatment
-
Evers S, Goadsby PJ. Hypnic headache: Clinical features, pathophysiology and treatment. Neurology. 2003;60:905-909.
-
(2003)
Neurology
, vol.60
, pp. 905-909
-
-
Evers, S.1
Goadsby, P.J.2
-
5
-
-
0030463698
-
Lithium neurotoxicity at low therapeutic doses hypotheses for causes and mechanism of action following a retrospective analysis of published case reports
-
Emilien G, Maloteaux JM. Lithium neurotoxicity at low therapeutic doses hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Acta Neurol Belg. 1996;96:281-293.
-
(1996)
Acta Neurol Belg
, vol.96
, pp. 281-293
-
-
Emilien, G.1
Maloteaux, J.M.2
-
6
-
-
1442359548
-
Topiramate for migraine prevention
-
Brandes JL, Sapel JR, Diamond M, et al. Topiramate for migraine prevention. JAMA. 2004;291:965-973.
-
(2004)
JAMA
, vol.291
, pp. 965-973
-
-
Brandes, J.L.1
Sapel, J.R.2
Diamond, M.3
-
7
-
-
0003150278
-
An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action
-
Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2004;41:S3-S9.
-
(2004)
Epilepsia
, vol.41
-
-
Shank, R.P.1
Gardocki, J.F.2
Streeter, A.J.3
Maryanoff, B.E.4
-
8
-
-
0036168826
-
Control of topiramate-induced paresthesias with supplemental potassium
-
Silberstein SD. Control of topiramate-induced paresthesias with supplemental potassium. Headache. 2002;42:85.
-
(2002)
Headache
, vol.42
, pp. 85
-
-
Silberstein, S.D.1
-
9
-
-
13244283194
-
Hypothyroidism in the elderly: Pathophysiology, diagnosis, and treatment
-
Laurberg P, Andersen S, Bulow Pedersen I, Carle A. Hypothyroidism in the elderly: Pathophysiology, diagnosis, and treatment. Drugs Aging. 2005;22:23-38.
-
(2005)
Drugs Aging
, vol.22
, pp. 23-38
-
-
Laurberg, P.1
Andersen, S.2
Bulow Pedersen, I.3
Carle, A.4
-
10
-
-
0345327706
-
Successful treatment of hypnic headache syndrome with acetazolamide
-
Sibon I, Ghorayeb I, Henry P. Successful treatment of hypnic headache syndrome with acetazolamide. Neurology. 2003;61:1157-1158.
-
(2003)
Neurology
, vol.61
, pp. 1157-1158
-
-
Sibon, I.1
Ghorayeb, I.2
Henry, P.3
-
11
-
-
0036754793
-
Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate
-
Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache. 2002;42:796-803.
-
(2002)
Headache
, vol.42
, pp. 796-803
-
-
Mathew, N.T.1
Kailasam, J.2
Meadors, L.3
|